HCSG (Healthcare Services Group) Research & Development: $0 Mil (TTM As of Mar. 2026)


HCSG Healthcare Services Group Inc HCSG
73 GF Score
Price $23.58
GF Value $14.08
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Healthcare Services Group Research & Development?

Healthcare Services Group HCSG +4.24% 73 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates HCSG with a GF Score™ of 73/100 and a GF Value™ of $14.08 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Healthcare Services Group's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Healthcare Services Group  (NAS:HCSG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Healthcare Services Group Research & Development Related Terms

Healthcare Services Group Research & Development Historical Data

* Premium members only.

The historical data trend for Healthcare Services Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthcare Services Group Research & Development Chart

Healthcare Services Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Healthcare Services Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HCSG
73GF Score
Healthcare Services Group Inc HCSG
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healthcare Services Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Healthcare Services Group (HCSG) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Healthcare Services Group and its competitors.
Is Healthcare Services Group's Research & Development too high?
Healthcare Services Group's current Research & Development is $0 Mil. Overall, Healthcare Services Group has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Healthcare Services Group's Research & Development compare to ARDT and AGL?
Healthcare Services Group's Research & Development of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Healthcare Services Group and its competitors. Healthcare Services Group's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare Services Group stock overvalued right now?
Based on GuruFocus' analysis, Healthcare Services Group (HCSG) is currently considered Significantly Overvalued. The stock's GF Value™ is $14.08, compared to a current price of $23.58 — trading 67.5% above its estimated fair value. The current Research & Development is $0 Mil. Healthcare Services Group's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Healthcare Services Group (HCSG), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healthcare Services Group (HCSG) Overvalued in 2026?

Based on GuruFocus' analysis, Healthcare Services Group stock appears to be overvalued. The current stock price of $23.58 is trading 67.5% above its estimated GF Value™ of $14.08. GuruFocus considers Healthcare Services Group to be Significantly Overvalued.

Key valuation signals for HCSG:

  • Research & Development: $0 Mil
  • GF Value™: $14.08 vs. price of $23.58 (67.5% above fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the HCSG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healthcare Services Group Business Description

Address 3220 Tillman Drive, Suite 300, Bensalem, PA, USA, 19020
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company manages and evaluates its operations in two reportable segments: Environmental Services segment includes housekeeping, management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services, linen and other services; and Dietary Segment includes dietary department services, food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America. The Environmental Services segment derives maximum revenue.
73GF Score

Get the complete analysis for HCSG

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.58
Price
$14.08
GF Value